Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Science & Technology Development Fund Authority presents new antiviral nucleosides

Feb. 2, 2022

Celsion's DNA-based approach for SARS-CoV-2 vaccine to be studied in NHP challenge study

Feb. 1, 2022

STI-1558 strongly inhibits Omicron variant in cell-based assays

Jan. 31, 2022

Cocrystal selects oral antiviral candidates for SARS-CoV-2

Jan. 28, 2022

S2K146 protects against SARS-CoV-2 infection in preclinical models

Jan. 27, 2022

Anixa and MolGenie report in vitro data on SARS-CoV-2 protease inhibitor

Jan. 25, 2022

CBD inhibits SARS-CoV-2 replication during early stages of infection in mice

Jan. 25, 2022

Chinese researchers patent new antibacterial compounds

Jan. 25, 2022

Sorrento's STI-9167 neutralizes Omicron and Omicron (+R346k) variants of SARS-CoV-2

Jan. 24, 2022

Macolacin, a novel naturally inspired antibiotic with efficacy against MDR pathogens

Jan. 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...